-
Tytuł:
-
[Security of supply: Getting to know more about the organization of suppliers].
-
Autorzy:
-
Vergne H; UF Évaluation et achat des médicaments, Agence générale des équipements et des produits de santé (AGEPS), Assistance publique-Hôpitaux de Paris (AP-HP), 7, rue du Fer-à-Moulin, 75005 Paris, France; Service Évaluations Pharmaceutiques et Bon Usage, AGEPS, AP-HP-Hôpitaux de Paris (AP-HP), 7, rue du Fer-à-Moulin, 75005 Paris, France. Electronic address: .
Loubière A; UF Évaluation et achat des médicaments, Agence générale des équipements et des produits de santé (AGEPS), Assistance publique-Hôpitaux de Paris (AP-HP), 7, rue du Fer-à-Moulin, 75005 Paris, France; Service Évaluations Pharmaceutiques et Bon Usage, AGEPS, AP-HP-Hôpitaux de Paris (AP-HP), 7, rue du Fer-à-Moulin, 75005 Paris, France.
Lawruk A; UF Évaluation et achat des médicaments, Agence générale des équipements et des produits de santé (AGEPS), Assistance publique-Hôpitaux de Paris (AP-HP), 7, rue du Fer-à-Moulin, 75005 Paris, France; Service Évaluations Pharmaceutiques et Bon Usage, AGEPS, AP-HP-Hôpitaux de Paris (AP-HP), 7, rue du Fer-à-Moulin, 75005 Paris, France.
Poisson N; UF Évaluation et achat des médicaments, Agence générale des équipements et des produits de santé (AGEPS), Assistance publique-Hôpitaux de Paris (AP-HP), 7, rue du Fer-à-Moulin, 75005 Paris, France; Service Évaluations Pharmaceutiques et Bon Usage, AGEPS, AP-HP-Hôpitaux de Paris (AP-HP), 7, rue du Fer-à-Moulin, 75005 Paris, France.
Paubel P; Service Évaluations Pharmaceutiques et Bon Usage, AGEPS, AP-HP-Hôpitaux de Paris (AP-HP), 7, rue du Fer-à-Moulin, 75005 Paris, France; Faculté de pharmacie de Paris, Institut Droit et Santé, Inserm UMR S 1145, Université de Paris, 4, avenue de l'Observatoire, 75006 Paris, France.
-
Transliterated Title:
-
Sécurité d’approvisionnement : mieux connaître l’organisation des fournisseurs.
-
Źródło:
-
Annales pharmaceutiques francaises [Ann Pharm Fr] 2022 Jan; Vol. 80 (1), pp. 89-100. Date of Electronic Publication: 2021 Mar 27.
-
Typ publikacji:
-
Journal Article
-
Język:
-
French
-
Imprint Name(s):
-
Publication: Paris : Elsevier Masson Editeur
Original Publication: Paris : Masson et Cie
-
MeSH Terms:
-
Retrospective Studies*
Europe ; France
-
Contributed Indexing:
-
Keywords: Approvisionnement; Drugs of major therapeutic interest; Fournisseurs; Médicaments d’intérêt thérapeutique majeur; Plan de gestion des pénuries; Rupture; Shortage; Shortage management plan; Suppliers; Supply
-
Entry Date(s):
-
Date Created: 20210331 Date Completed: 20211228 Latest Revision: 20211228
-
Update Code:
-
20240105
-
DOI:
-
10.1016/j.pharma.2021.03.004
-
PMID:
-
33785370
-
Objectives: The worsening pharmaceutical products shortage required the central purchasing structure of AP-HP to include a new criterion on supply safety in the tenders' procedures. Each provider answering to the tender needs to complete a dedicated form. The aim is to review the collected information and assess its relevance.
Methods: This study is based on a retrospective analysis conducted on the last 2 tenders' procedures forms (one started in September 2019 and the other in February 2020).
Results: These 2 tenders' procedures were composed of 155 lots. The form response rate was 81,4%. The average rating on 20 was 10,9±3,8. The rates could be very variable depending on the lots. Regarding the 2020s tenders procedures, 57.8% of specialties were classified as drugs of major therapeutic interest. A shortage management plan exists for 24.0% of them. Providers indicated several sources of raw materials (36,1%) and several factories (35,5%). The average advanced stock was 4.1±3.8 months in France and 2.3±2.6 months in Europe. The information system implemented by suppliers scored an average of 15 out of 20.
Conclusions: This study allowed us to know better the suppliers' organisation. The concerning points are the low stocks and the discrepancies in the suppliers' drugs of major therapeutic interest classification of a same product and the existence of a shortage management plan. This form will be maintained with more specific questions. An assessment will be done to determine the relevance of this form to prevent disruptions.
(Copyright © 2021 Académie Nationale de Pharmacie. Published by Elsevier Masson SAS. All rights reserved.)
